References
Non-Small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899–909
Albain KS et al. (1991) Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 9: 1618–1626
Ludbrook JJ et al. (2003) Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Onc Biol Phys 55: 1321–1330
Lilenbaum R (2003) Management of advanced non-small-cell lung cancer in elderly populations. Clin Lung Cancer 5: 169–173
Weinmann M et al. (2003) Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 40: 1–16
Jiroutek M et al. (1998) Prognostic factors in advanced NSCLC: analysis of ECOG trials from 1981–1992. [abstract] Proc Am Soc Clin Oncol 17: 1777. a1774
Acknowledgements
The synopsis was written by David Bruce, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Temel, J. Can weight loss at presentation predict patient outcome in lung cancer?. Nat Rev Clin Oncol 1, 68–69 (2004). https://doi.org/10.1038/ncponc0033
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0033
- Springer Nature Limited
This article is cited by
-
Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study
Supportive Care in Cancer (2017)